LadRx Corporation
LADX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.01 | 0.00 |
| FCF Yield | -68,922.72% | 84,458.33% | -225,722.97% | -107.23% |
| EV / EBITDA | -0.83 | -0.11 | -1.01 | -0.27 |
| Quality | ||||
| ROIC | 33.71% | 41.27% | 47.18% | 138.63% |
| Gross Margin | 0.00% | 50.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 768.53 | -0.44 | 2,439.62 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 190,479.95% | 190,479.95% | 260,764.97% | 260,764.97% |
| Free Cash Flow Growth | -178.69% | 134.92% | -161,131.84% | -21,103.65% |
| Safety | ||||
| Net Debt / EBITDA | 0.29 | 1.14 | 0.07 | 0.63 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -155,139.15 | -27,477.49 | -61,521.65 | -53,529.25 |